Search Within

Raajit Kumar Rampal

Formats
  1. Meeting Abstract (191)
  2. Journal Article (123)
  3. Review (21)
  4. Research Letter (10)
  5. Book Section (2)
  6. Editorial (2)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Adult Leukemia (351)
  2. Center for Hematologic Malignancies (351)
  3. Department of Medicine (351)
  4. Hematologic Malignancies, Division of (351)
  5. GSK Faculty (135)
  6. Executive Committee, Center for Hematologic Malignancies (131)

More Groups

People
  1. Ross Levine (87)
  2. Omar Abdel-Wahab (64)
  3. Martin Tallman (41)
  4. Eli Diamond (34)
  5. Ahmet Dogan (30)
  6. Minal Patel (29)

More People

Years
  1. 2025 (15)
  2. 2024 (35)
  3. 2023 (42)
  4. 2022 (36)
  5. 2021 (36)
  6. 2020 (26)

More Years

Publications
  1. Blood (148)
  2. Journal of Clinical Oncology (18)
  3. Blood Advances (15)
  4. Clinical Lymphoma, Myeloma and Leukemia (15)
  5. Haematologica (13)
  6. British Journal of Haematology (10)

More Publications

Publishers
  1. American Society of Hematology (164)
  2. Elsevier Inc. (24)
  3. Nature Publishing Group (22)
  4. American Society of Clinical Oncology (18)
  5. Ferrata Storti Foundation (13)
  6. American Association for Cancer Research (12)

More Publishers

Results (351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutational profile of children with myeloproliferative neoplasms
    Meeting Abstract

    Rutherford, K.; Farnoud, N.; Krishnan, A.; Rampal, R. K.; Levine, R. L.; Kucine, N.
    Blood (2022)

    Fulltext@MSK | Save
  • MYLOX-1: An open-label, phase IIa study of the safety, tolerability, pharmacokinetics and pharmacodynamics of oral LOXL2 inhibitor, GB2064, in myelofibrosis
    Meeting Abstract

    Verstovsek, S.; Mascarenhas, J.; Rampal, R. K.; Cilloni, D.; Harrison, C.; Jacoby, B.; Slack, R. J.; Aslanis, V.; Singh, B.; Lindmark, B.
    Blood (2022)

    Fulltext@MSK | Save
  • Molecularly targeted combination therapy for advanced phase myeloproliferative neoplasm: MPN-RC 119
    Meeting Abstract

    Bar-Natan, M.; Mascarenhas, J.; Gerds, A. T.; Mesa, R.; Gupta, V.; Kremyanskaya, M.; Dougherty, M.; Fabris, F.; Johnson, K.; Yu, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with newly diagnosed and relapsed acute leukemia
    Meeting Abstract

    Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Clinical benefit associated with biomarker changes indicative of disease modification in patients with myelofibrosis treated with the BET inhibitor pelabresib as monotherapy or in combination with ruxolitinib
    Meeting Abstract

    Scandura, J.; Verstovsek, S.; Kremyanskaya, M.; Talpaz, M.; Rampal, R. K.; Vannucchi, A.; Gupta, V.; Palandri, F.; Patriarca, A.; Bose, P.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Pelabresib (CPI-0610) combined with ruxolitinib for JAK inhibitor treatment-naïve patients with myelofibrosis: Durability of response and safety beyond week 24
    Meeting Abstract

    Mascarenhas, J.; Kremyanskaya, M.; Patriarca, A.; Gupta, V.; Palandri, F.; Devos, T.; Rampal, R. K.; Talpaz, M.; Vannucchi, A.; Kuykendall, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Preliminary data from the phase I/II study of TP-3654, a selective oral PIM1 kinase inhibitor, in patients with myelofibrosis previously treated with or ineligible for JAK inhibitor therapy
    Meeting Abstract

    El Chaer, F.; McCloskey, J.; Rein, L. A. M.; Brown, R. A.; Green, S. D.; Pu, J. J.; Shirane, S.; Shimoda, K.; Ichii, M.; Yuda, J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of add-on parsaclisib to ruxolitinib therapy in myelofibrosis patients with suboptimal response to ruxolitinib: Final results from a phase 2 study
    Meeting Abstract

    Yacoub, A.; Borate, U.; Rampal, R. K.; Ali, H.; Wang, E.; Gerds, A. T.; Hobbs, G. S.; Kremyanskaya, M.; Winton, E.; O'Connell, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The high mobility group A1 chromatin regulator drives immune evasion during MPN progression by repressing genes involved in antigen presentation
    Meeting Abstract

    Kim, J.; Kim, J. H.; Cope, L.; Li, L.; Rampal, R. K.; Koche, R.; Spivak, J. L.; Moliterno, A. R.; Resar, L.
    Blood (2022)

    Fulltext@MSK | Save
  • Role of allogeneic transplantation in chronic myelomonocytic leukemia: An international collaborative analysis
    Journal Article

    Robin, M.; de Wreede, L. C.; Padron, E.; Bakunina, K.; Fenaux, P.; Koster, L.; Nazha, A.; Beelen, D. W.; Rampal, R. K.; Sockel, K.; more...
    Blood (2022)

    Fulltext@MSK | Save